These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25839195)

  • 1. Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit.
    Mane DR; Bhat K; Kale AD; Hallikerimath S
    Biotech Histochem; 2015; 90(7):544-51. PubMed ID: 25839195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
    Tiitta O; Happonen RP; Virtanen I; Luomanen M
    J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia.
    Caldeira PC; Abreu MH; Batista AC; do Carmo MA
    J Oral Pathol Med; 2011 Feb; 40(2):153-9. PubMed ID: 20969633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma.
    Häkkinen L; Kainulainen T; Salo T; Grenman R; Larjava H
    Oral Dis; 1999 Jul; 5(3):210-7. PubMed ID: 10483066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of Tenascin in embryogenesis, tumorigenesis and inflammatory oral mucosa.
    Mane DR; Kale AD; Naik VV
    Arch Oral Biol; 2011 Jul; 56(7):655-63. PubMed ID: 21208610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
    Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR.
    Caldeira PC; Aguiar MC; Mesquita RA; do Carmo MA
    J Oral Pathol Med; 2011 Apr; 40(4):305-11. PubMed ID: 21208285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins (HSP70 and HSP27) as markers of epithelial dysplasia in oral leukoplakia.
    Seoane JM; Varela-Centelles PI; Ramirez JR; Cameselle-Teijeiro J; Romero MA; Aguirre JM
    Am J Dermatopathol; 2006 Oct; 28(5):417-22. PubMed ID: 17012917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-malignant lesions of the oral mucosa in a South African sample--a clinicopathological study.
    Feller L; Altini M; Slabbert H
    J Dent Assoc S Afr; 1991 May; 46(5):261-5. PubMed ID: 1962315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
    Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
    J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
    Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correlation analysis between frequency of micronucleated cells of exfoliated oral mucosa cells and oral mucosa cells in different grading of oral leukoplakia lesions].
    Sun Z; Li N; Zhang Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Nov; 35(6):439-41. PubMed ID: 11780528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological classification of oral leukoplakia (author's transl)].
    Burkhardt A; Seifert G
    Dtsch Med Wochenschr; 1977 Feb; 102(7):223-9. PubMed ID: 836383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of risk factors for carcinogenesis of oral leukoplakia].
    Lan AX; Guan XB; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jun; 44(6):327-31. PubMed ID: 19953947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.